Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05980000 |
|---|---|
| Brief Title: | Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma (Rambro2) |
| First Submitted : | July 30, 2023 |
| First Submitted that Met QC Criteria : | July 30, 2023 |
| First Posted : | August 7, 2023 |
| Last Update Submitted that Met QC Criteria : | January 27, 2024 |
| Last Update Posted : | January 30, 2024 |